NEW: FDA's Julie Tierney and Dr. Nicole Verdun to Speak at ASGCT's Policy Summit (Sept. 23-24). Register Now!
Four elected members join the Board of Directors at the 21st Annual Meeting.
After a monthlong election, members of the American Society of Gene & Cell Therapy have elected four new members to the Society's Board of Directors, including a new incoming vice president.
Each elected member will serve a three-year term, including the incoming vice president who will enter the leadership succession line. Stephen Russell, MD, PhD will serve a yearlong term as vice president before serving as ASGCT's president-elect and, finally, president through the 2021 annual meeting.
All four of the following newly-elected members will begin their terms on the Board of Directors during the 21st Annual Meeting next month at the Hilton Chicago:
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico